Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

429 public trials 53 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB)

NCT04891770

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
  • Aalborg University Hospital Aalborg, Denmark
  • Aarhus University Hospital Aarhus N, Denmark
View all 26 locations
View Trial Details
Completed

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection

NCT04439539

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Ruane Clinical Research Group Inc Los Angeles, California, United States
  • UPMC Center For Liver Diseases Pittsburgh, Pennsylvania, United States
  • Liver Institute Northwest Seattle, Washington, United States
  • University of Calgary Calgary, Alberta, Canada
View all 47 locations
View Trial Details
Completed

A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection

NCT05123599

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • UZ Antwerpen Edegem, Belgium
  • UZA-SGS Edegem, Belgium
  • Hopital Beaujon Clichy, France
  • Hopital de La Croix Rousse Lyon, France
View all 13 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B

NCT05828745

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • First Hospital of Jilin University Changchun, Jilin, China
  • PCRN Trials Limited, trading as PCRN Auckland, Level 2, 2 Fred Thomas Drive, Takapuna, Auckland, 0622, New Zealand (hereinafter referred to as "Institution") Auckland, New Zealand
View Trial Details
Completed

An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants

NCT05275023

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Toronto General Hospital Toronto, Ontario, Canada
  • Fakultni nemocnice Hradec Kralove Hradec Králové, Czechia
  • IKEM Prague, Czechia
  • Hopital Beaujon Clichy, France
View all 26 locations
View Trial Details

Related conditions